FDA — authorised 7 April 1960
- Status: approved
🇺🇸 Combipres in United States
FDA authorised Combipres on 7 April 1960
Marketing authorisations
FDA — authorised 3 September 1974
- Application: NDA017503
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Local brand name: COMBIPRES
- Indication: TABLET — ORAL
- Status: approved
Combipres in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Combipres approved in United States?
Yes. FDA authorised it on 7 April 1960; FDA authorised it on 3 September 1974.
Who is the marketing authorisation holder for Combipres in United States?
University Hospital Birmingham is the originator. The local marketing authorisation holder may differ — check the official source linked above.